Why is Bharat Parenter. falling/rising?
2025-12-02 01:04:00Short-Term Price Movement and Investor Activity On 01-Dec, Bharat Parenterals closed at ₹1,154.90, marking an increase of ₹3.95 or 0.34% by 9:01 PM. This rise is part of a two-day consecutive gain period, during which the stock has appreciated by 4.43%. Notably, the stock opened with a gap up of 4.26%, signalling strong buying interest at the start of the trading session. The intraday high reached ₹1,200, representing a 4.26% increase from the previous close, underscoring the bullish sentiment among traders on that day. Investor participation has also shown a marked increase, with delivery volumes on 28 Nov rising by 233.26% compared to the five-day average. This surge in delivery volume indicates that more investors are holding shares rather than trading intraday, whi...
Read More
Bharat Parenter. Sees Revision in Market Assessment Amidst Challenging Fundamentals
2025-12-01 10:09:16Bharat Parenter., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The recent shift in analytical perspective highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the company’s current position within a competitive and volatile market environment.
Read More
Bharat Parenterals Faces Financial Trend Adjustments Amid Mixed Performance Indicators
2025-11-13 11:04:24Bharat Parenterals has experienced a flat financial performance for the quarter ending September 2025, despite a 22.69% increase in net sales for the first nine months. The company maintains a strong balance sheet with a commendable debt-equity ratio, though recent quarterly sales have declined significantly.
Read MoreHow has been the historical performance of Bharat Parenter.?
2025-11-13 00:33:49Answer: The historical performance of Bharat Parenter shows significant fluctuations in key financial metrics over the years, culminating in a challenging fiscal year ending March 2025. Breakdown: Bharat Parenter's net sales have shown a steady increase from INR 204.64 crore in March 2021 to INR 340.38 crore in March 2025, reflecting a strong growth trajectory. However, total operating income followed a similar trend, reaching INR 340.38 crore in March 2025, up from INR 261.22 crore in March 2024. Despite this growth in revenue, the company faced rising raw material costs, which increased from INR 127.13 crore in March 2021 to INR 178.17 crore in March 2025. Consequently, total expenditure also rose significantly, leading to an operating profit (PBDIT) of only INR 2.70 crore in March 2025, a sharp decline from INR 27.08 crore in March 2024. This decline in profitability is further highlighted by a profit b...
Read MoreWhy is Bharat Parenter. falling/rising?
2025-11-11 23:46:16As of 11-Nov, Bharat Parenterals Ltd's stock price is currently at Rs 1,097.35, reflecting a decline of Rs 59.45 or 5.14%. The stock has been on a downward trend, having lost 10.23% over the past week and 14.27% over the past month. Despite opening with a gain of 2.83% today and reaching an intraday high of Rs 1,189.5, it has since fallen to a low of Rs 1,071.05. The stock has been highly volatile, with an intraday volatility of 5.24%, and it is trading below all key moving averages. While there was a notable increase in delivery volume, the overall sentiment remains negative due to weak long-term fundamentals, including a significant decline in operating profits and low profitability as indicated by a return on equity of only 8.64%. In the broader market context, Bharat Parenterals has underperformed significantly compared to the benchmark Sensex, which has gained 0.49% over the past week while the stock...
Read MoreWhy is Bharat Parenter. falling/rising?
2025-11-10 23:51:38As of 10-Nov, Bharat Parenterals Ltd is experiencing a decline in its stock price, currently at Rs 1,156.10, which represents a decrease of Rs 38.9 or 3.26%. The stock has been underperforming, having lost 5.43% over the last three days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 75.61% compared to the 5-day average. Over the past week, the stock has decreased by 2.29%, and its year-to-date performance shows a decline of 21.23%, indicating ongoing challenges for the company. In the broader market context, the Sensex has shown a slight decline of 0.53% over the past week, which suggests that the market is experiencing some weakness, but Bharat Parenterals' decline is more pronounced. The stock's performance over the last month has been particularly poor, with a...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
31-Jan-2026 | Source : BSEcopy of newspaper advertisement for the unaudited financial results for the quarter and nine months ended December 31 2025.
Financial Results For The Quarter And Nine Months Ended On December 31 2025.
30-Jan-2026 | Source : BSEUnaudited Financial Results for the Quarter and Nine Months Ended on December 31 2025.
Board Meeting Outcome for Outcome Of Board Meeting For The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 31 2025.
30-Jan-2026 | Source : BSEOutcome of Board Meeting held on January 30 2026.
Corporate Actions
No Upcoming Board Meetings
Bharat Parenterals Ltd has declared 10% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available